COVID-19 Gene Panel
956 possibles genes were retrivied by gene atomization using pubmed.mineR. This information needs human curation.
Table 1. Genes cited in Abstracts in COVID-19 literature. We are developing a search bar. Help us!
| Symbol | Description | Citation Frequency | Number of Articles |
|---|---|---|---|
| AAK1 | AP2 associated kinase 1 | 7 | 8 |
| ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | 1 | 1 |
| ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | 4 | 7 |
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 2 | 3 |
| ABHD6 | abhydrolase domain containing 6 | 1 | 1 |
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 1 | 1 |
| ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) | 125 | 66 |
| ACADM | acyl-CoA dehydrogenase, C-4 to C-12 straight chain | 1 | 1 |
| ACD | adrenocortical dysplasia homolog (mouse) | 2 | 4 |
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 421 | 527 |
| ACE2 | angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 | 4322 | 2065 |
| ACR | acrosin | 9 | 14 |
| ACTB | actin, beta | 1 | 1 |
| ACVRL1 | activin A receptor type II-like 1 | 2 | 2 |
| ADA | adenosine deaminase | 9 | 13 |
| ADAM10 | ADAM metallopeptidase domain 10 | 3 | 3 |
| ADAM17 | ADAM metallopeptidase domain 17 | 38 | 29 |
| ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | 36 | 18 |
| ADAMTS17 | ADAM metallopeptidase with thrombospondin type 1 motif, 17 | 1 | 1 |
| ADAP2 | ArfGAP with dual PH domains 2 | 2 | 1 |
| ADAR | adenosine deaminase, RNA-specific | 4 | 5 |
| ADC | arginine decarboxylase | 2 | 4 |
| ADK | adenosine kinase | 2 | 1 |
| ADORA2A | adenosine A2a receptor | 1 | 1 |
| ADRA2A | adrenoceptor alpha 2A | 1 | 1 |
| ADRA2C | adrenoceptor alpha 2C | 1 | 1 |
| ADRB2 | adrenoceptor beta 2, surface | 1 | 2 |
| AEBP2 | AE binding protein 2 | 1 | 1 |
| AFM | afamin | 3 | 4 |
| AFP | alpha-fetoprotein | 10 | 3 |
| AGA | aspartylglucosaminidase | 5 | 17 |
| AGER | advanced glycosylation end product-specific receptor | 1 | 1 |
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 3 | 4 |
| AGTR1 | angiotensin II receptor, type 1 | 1 | 1 |
| AGTR2 | angiotensin II receptor, type 2 | 5 | 3 |
| AHR | aryl hydrocarbon receptor | 1 | 59 |
| AIM2 | absent in melanoma 2 | 2 | 1 |
| AIP | aryl hydrocarbon receptor interacting protein | 12 | 3 |
| AKR1B10 | aldo-keto reductase family 1, member B10 (aldose reductase) | 1 | 1 |
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 5 | 6 |
| ALB | albumin | 28 | 28 |
| ALK | anaplastic lymphoma receptor tyrosine kinase | 2 | 1 |
| ALOX12 | arachidonate 12-lipoxygenase | 1 | 1 |
| ALOX5 | arachidonate 5-lipoxygenase | 1 | 1 |
| ALOX5AP | arachidonate 5-lipoxygenase-activating protein | 1 | 1 |
| AMH | anti-Mullerian hormone | 2 | 2 |
| AMN | amnion associated transmembrane protein | 5 | 1 |
| ANG | angiogenin, ribonuclease, RNase A family, 5 | 15 | 104 |
| ANK2 | ankyrin 2, neuronal | 1 | 1 |
| ANPEP | alanyl (membrane) aminopeptidase | 9 | 9 |
| ANXA1 | annexin A1 | 1 | 1 |
| ANXA7 | annexin A7 | 1 | 1 |
| AP2M1 | adaptor-related protein complex 2, mu 1 subunit | 2 | 1 |
| APC | adenomatous polyposis coli | 21 | 15 |
| APCDD1 | adenomatosis polyposis coli down-regulated 1 | 1 | 1 |
| APEX2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 | 1 | 2 |
| APOA1 | apolipoprotein A-I | 5 | 2 |
| APOA5 | apolipoprotein A-V | 1 | 1 |
| APOBEC3A | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | 1 | 1 |
| APOE | apolipoprotein E | 4 | 4 |
| APOL1 | apolipoprotein L, 1 | 15 | 12 |
| APP | amyloid beta (A4) precursor protein | 8 | 250 |
| AQP4 | aquaporin 4 | 1 | 2 |
| AR | androgen receptor | 51 | 36 |
| ARC | activity-regulated cytoskeleton-associated protein | 5 | 13 |
| ARG1 | arginase, liver | 1 | 2 |
| ASL | argininosuccinate lyase | 8 | 7 |
| ATF3 | activating transcription factor 3 | 1 | 1 |
| ATG16L1 | autophagy related 16-like 1 (S. cerevisiae) | 4 | 2 |
| ATG5 | autophagy related 5 | 2 | 2 |
| ATM | ataxia telangiectasia mutated | 15 | 8 |
| ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | 2 | 2 |
| ATP6V0D1 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 | 1 | 1 |
| ATR | ataxia telangiectasia and Rad3 related | 3 | 6 |
| AVP | arginine vasopressin | 8 | 4 |
| AXIN2 | axin 2 | 1 | 1 |
| AXL | AXL receptor tyrosine kinase | 8 | 5 |
| AZU1 | azurocidin 1 | 1 | 2 |
| BAD | BCL2-associated agonist of cell death | 2 | 100 |
| BCL2 | B-cell CLL/lymphoma 2 | 2 | 3 |
| BCL2L1 | BCL2-like 1 | 5 | 5 |
| BCL6 | B-cell CLL/lymphoma 6 | 1 | 1 |
| BCR | breakpoint cluster region | 11 | 10 |
| BDKRB2 | bradykinin receptor B2 | 1 | 1 |
| BDNF | brain-derived neurotrophic factor | 1 | 2 |
| BECN1 | beclin 1, autophagy related | 1 | 1 |
| BID | BH3 interacting domain death agonist | 21 | 33 |
| BIN1 | bridging integrator 1 | 1 | 1 |
| BLM | Bloom syndrome, RecQ helicase-like | 1 | 1 |
| BLNK | B-cell linker | 1 | 1 |
| BMP2 | bone morphogenetic protein 2 | 1 | 1 |
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 1 | 1 |
| BPI | bactericidal/permeability-increasing protein | 2 | 3 |
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 1 | 2 |
| BRCA1 | breast cancer 1, early onset | 5 | 4 |
| BRCA2 | breast cancer 2, early onset | 2 | 2 |
| BRD2 | bromodomain containing 2 | 3 | 1 |
| BRD4 | bromodomain containing 4 | 1 | 1 |
| BSG | basigin (Ok blood group) | 16 | 19 |
| BST2 | bone marrow stromal cell antigen 2 | 3 | 2 |
| BTK | Bruton agammaglobulinemia tyrosine kinase | 29 | 11 |
| BTLA | B and T lymphocyte associated | 2 | 3 |
| C2 | complement component 2 | 6 | 10 |
| C3 | complement component 3 | 50 | 37 |
| C5 | complement component 5 | 17 | 17 |
| C6 | complement component 6 | 1 | 4 |
| C7 | complement component 7 | 2 | 4 |
| CA1 | carbonic anhydrase I | 1 | 1 |
| CAD | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 89 | 52 |
| CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 1 | 1 |
| CALR | calreticulin | 1 | 1 |
| CAPS | calcyphosine | 5 | 17 |
| CARS | cysteinyl-tRNA synthetase | 1 | 11 |
| CASP1 | caspase 1, apoptosis-related cysteine peptidase | 1 | 1 |
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 9 | 10 |
| CASP6 | caspase 6, apoptosis-related cysteine peptidase | 1 | 1 |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 3 | 4 |
| CAT | catalase | 12 | 52 |
| CAV1 | caveolin 1, caveolae protein, 22kDa | 2 | 2 |
| CBS | cystathionine-beta-synthase | 1 | 1 |
| CCDC88A | coiled-coil domain containing 88A | 1 | 1 |
| CCL11 | chemokine (C-C motif) ligand 11 | 1 | 1 |
| CCL17 | chemokine (C-C motif) ligand 17 | 4 | 1 |
| CCL2 | chemokine (C-C motif) ligand 2 | 21 | 33 |
| CCL20 | chemokine (C-C motif) ligand 20 | 5 | 6 |
| CCL25 | chemokine (C-C motif) ligand 25 | 1 | 1 |
| CCL3 | chemokine (C-C motif) ligand 3 | 2 | 7 |
| CCL4 | chemokine (C-C motif) ligand 4 | 6 | 8 |
| CCL5 | chemokine (C-C motif) ligand 5 | 8 | 11 |
| CCL7 | chemokine (C-C motif) ligand 7 | 1 | 1 |
| CCL8 | chemokine (C-C motif) ligand 8 | 2 | 4 |
| CCND1 | cyclin D1 | 1 | 1 |
| CCR1 | chemokine (C-C motif) receptor 1 | 7 | 7 |
| CCR2 | chemokine (C-C motif) receptor 2 | 2 | 2 |
| CCR3 | chemokine (C-C motif) receptor 3 | 1 | 1 |
| CCR4 | chemokine (C-C motif) receptor 4 | 5 | 3 |
| CCR5 | chemokine (C-C motif) receptor 5 (gene/pseudogene) | 10 | 8 |
| CCR7 | chemokine (C-C motif) receptor 7 | 1 | 3 |
| CCS | copper chaperone for superoxide dismutase | 36 | 17 |
| CD14 | CD14 molecule | 3 | 15 |
| CD160 | CD160 molecule | 1 | 1 |
| CD163 | CD163 molecule | 6 | 8 |
| CD177 | CD177 molecule | 1 | 1 |
| CD19 | CD19 molecule | 14 | 25 |
| CD1A | CD1a molecule | 1 | 1 |
| CD2 | CD2 molecule | 1 | 1 |
| CD200 | CD200 molecule | 3 | 2 |
| CD209 | CD209 molecule | 10 | 6 |
| CD28 | CD28 molecule | 3 | 3 |
| CD33 | CD33 molecule | 8 | 2 |
| CD34 | CD34 molecule | 3 | 5 |
| CD36 | CD36 molecule (thrombospondin receptor) | 1 | 1 |
| CD38 | CD38 molecule | 6 | 11 |
| CD4 | CD4 molecule | 163 | 328 |
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 4 | 5 |
| CD40LG | CD40 ligand | 1 | 1 |
| CD46 | CD46 molecule, complement regulatory protein | 10 | 1 |
| CD47 | CD47 molecule | 12 | 1 |
| CD5 | CD5 molecule | 2 | 2 |
| CD52 | CD52 molecule | 1 | 1 |
| CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 1 | 1 |
| CD6 | CD6 molecule | 3 | 7 |
| CD63 | CD63 molecule | 1 | 2 |
| CD68 | CD68 molecule | 9 | 13 |
| CD69 | CD69 molecule | 4 | 5 |
| CD72 | CD72 molecule | 1 | 1 |
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 3 | 1 |
| CD80 | CD80 molecule | 3 | 4 |
| CD81 | CD81 molecule | 1 | 1 |
| CD86 | CD86 molecule | 3 | 3 |
| CD8A | CD8a molecule | 3 | 4 |
| CD9 | CD9 molecule | 3 | 3 |
| CDA | cytidine deaminase | 1 | 4 |
| CDC42 | cell division cycle 42 | 1 | 3 |
| CDKN1C | cyclin-dependent kinase inhibitor 1C (p57, Kip2) | 1 | 1 |
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 2 | 2 |
| CEP250 | centrosomal protein 250kDa | 4 | 1 |
| CES2 | carboxylesterase 2 | 2 | 1 |
| CFD | complement factor D (adipsin) | 10 | 9 |
| CFI | complement factor I | 10 | 20 |
| CFP | complement factor properdin | 5 | 3 |
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 14 | 8 |
| CH25H | cholesterol 25-hydroxylase | 2 | 2 |
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 1 | 2 |
| CHM | choroideremia (Rab escort protein 1) | 40 | 13 |
| CHN2 | chimerin 2 | 1 | 1 |
| CIC | capicua transcriptional repressor | 7 | 4 |
| CIITA | class II, major histocompatibility complex, transactivator | 6 | 2 |
| CKM | creatine kinase, muscle | 2 | 2 |
| CLC | Charcot-Leyden crystal protein | 2 | 1 |
| CLEC1B | C-type lectin domain family 1, member B | 1 | 1 |
| CLEC4G | C-type lectin domain family 4, member G | 2 | 1 |
| CLEC4M | C-type lectin domain family 4, member M | 5 | 4 |
| COL6A3 | collagen, type VI, alpha 3 | 1 | 1 |
| COMP | cartilage oligomeric matrix protein | 1 | 1 |
| COMT | catechol-O-methyltransferase | 2 | 2 |
| COPE | coatomer protein complex, subunit epsilon | 7 | 525 |
| COX10 | cytochrome c oxidase assembly homolog 10 (yeast) | 1 | 1 |
| COX18 | cytochrome c oxidase assembly homolog 18 (yeast) | 1 | 1 |
| CP | ceruloplasmin (ferroxidase) | 311 | 106 |
| CPB2 | carboxypeptidase B2 (plasma) | 1 | 1 |
| CPD | carboxypeptidase D | 20 | 11 |
| CPE | carboxypeptidase E | 12 | 11 |
| CPM | carboxypeptidase M | 14 | 8 |
| CPQ | carboxypeptidase Q | 1 | 1 |
| CPS1 | carbamoyl-phosphate synthase 1, mitochondrial | 1 | 1 |
| CPZ | carboxypeptidase Z | 33 | 4 |
| CRIP2 | cysteine-rich protein 2 | 1 | 1 |
| CRP | C-reactive protein, pentraxin-related | 1036 | 811 |
| CRX | cone-rod homeobox | 2 | 2 |
| CS | citrate synthase | 91 | 62 |
| CSF1 | colony stimulating factor 1 (macrophage) | 2 | 1 |
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 1 | 1 |
| CSF3 | colony stimulating factor 3 (granulocyte) | 6 | 2 |
| CTGF | connective tissue growth factor | 1 | 1 |
| CTH | cystathionase (cystathionine gamma-lyase) | 4 | 2 |
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 2 | 4 |
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 2 | 2 |
| CTNS | cystinosin, lysosomal cystine transporter | 1 | 1 |
| CTRL | chymotrypsin-like | 7 | 2 |
| CTSB | cathepsin B | 13 | 14 |
| CTSS | cathepsin S | 17 | 4 |
| CUL3 | cullin 3 | 1 | 1 |
| CX3CL1 | chemokine (C-X3-C motif) ligand 1 | 1 | 1 |
| CX3CR1 | chemokine (C-X3-C motif) receptor 1 | 2 | 2 |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 6 | 6 |
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 43 | 28 |
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 1 | 2 |
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 1 | 2 |
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 5 | 6 |
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 1 | 3 |
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 3 | 2 |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 6 | 8 |
| CXCR1 | chemokine (C-X-C motif) receptor 1 | 2 | 2 |
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 7 | 6 |
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 3 | 7 |
| CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 | 1 | 2 |
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 2 | 3 |
| CYP27B1 | cytochrome P450, family 27, subfamily B, polypeptide 1 | 1 | 1 |
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 2 | 2 |
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 2 | 2 |
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 2 | 2 |
| CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 15 | 10 |
| CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 1 | 2 |
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 9 | 12 |
| CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 1 | 1 |
| DAAM1 | dishevelled associated activator of morphogenesis 1 | 1 | 1 |
| DBP | D site of albumin promoter (albumin D-box) binding protein | 10 | 6 |
| DBT | dihydrolipoamide branched chain transacylase E2 | 5 | 4 |
| DCC | deleted in colorectal carcinoma | 6 | 5 |
| DCD | dermcidin | 8 | 3 |
| DCN | decorin | 3 | 1 |
| DCT | dopachrome tautomerase | 9 | 8 |
| DDC | dopa decarboxylase (aromatic L-amino acid decarboxylase) | 2 | 2 |
| DDIT4 | DNA-damage-inducible transcript 4 | 1 | 1 |
| DDTL | D-dopachrome tautomerase-like | 1 | 1 |
| DEFA4 | defensin, alpha 4, corticostatin | 1 | 1 |
| DES | desmin | 9 | 86 |
| DHH | desert hedgehog | 9 | 2 |
| DHODH | dihydroorotate dehydrogenase (quinone) | 15 | 6 |
| DKK3 | dickkopf 3 homolog (Xenopus laevis) | 1 | 1 |
| DMD | dystrophin | 8 | 5 |
| DNAH7 | dynein, axonemal, heavy chain 7 | 1 | 2 |
| DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | 1 | 1 |
| DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 7 | 1 |
| DPP4 | dipeptidyl-peptidase 4 | 104 | 59 |
| DPP7 | dipeptidyl-peptidase 7 | 1 | 1 |
| DPT | dermatopontin | 3 | 2 |
| DPYD | dihydropyrimidine dehydrogenase | 1 | 1 |
| DSP | desmoplakin | 2 | 3 |
| DST | dystonin | 2 | 2 |
| DTL | denticleless E3 ubiquitin protein ligase homolog (Drosophila) | 2 | 1 |
| EBP | emopamil binding protein (sterol isomerase) | 17 | 8 |
| ECD | ecdysoneless homolog (Drosophila) | 3 | 5 |
| ECSIT | ECSIT homolog (Drosophila) | 1 | 1 |
| EDEM1 | ER degradation enhancer, mannosidase alpha-like 1 | 1 | 1 |
| EEA1 | early endosome antigen 1 | 2 | 1 |
| EED | embryonic ectoderm development | 3 | 1 |
| EFS | embryonal Fyn-associated substrate | 2 | 1 |
| EGF | epidermal growth factor | 6 | 8 |
| EGFR | epidermal growth factor receptor | 14 | 64 |
| EGR1 | early growth response 1 | 2 | 2 |
| ELANE | elastase, neutrophil expressed | 3 | 5 |
| EMB | embigin | 4 | 4 |
| EMD | emerin | 1 | 1 |
| EMILIN1 | elastin microfibril interfacer 1 | 2 | 1 |
| EMILIN2 | elastin microfibril interfacer 2 | 2 | 1 |
| ENDOU | endonuclease, polyU-specific | 4 | 9 |
| ENG | endoglin | 1 | 9 |
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 3 | 2 |
| EP300 | E1A binding protein p300 | 1 | 1 |
| EPO | erythropoietin | 12 | 7 |
| ERAP1 | endoplasmic reticulum aminopeptidase 1 | 5 | 3 |
| ERAP2 | endoplasmic reticulum aminopeptidase 2 | 5 | 3 |
| ERAS | ES cell expressed Ras | 10 | 14 |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 4 | 3 |
| ERCC1 | excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) | 1 | 1 |
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 2 | 6 |
| ERGIC1 | endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 | 1 | 1 |
| ESR1 | estrogen receptor 1 | 6 | 4 |
| EZH2 | enhancer of zeste homolog 2 (Drosophila) | 2 | 1 |
| F11 | coagulation factor XI | 1 | 1 |
| F2 | coagulation factor II (thrombin) | 2 | 4 |
| F5 | coagulation factor V (proaccelerin, labile factor) | 2 | 1 |
| F8 | coagulation factor VIII, procoagulant component | 3 | 1 |
| FABP5 | fatty acid binding protein 5 (psoriasis-associated) | 1 | 1 |
| FADS1 | fatty acid desaturase 1 | 2 | 2 |
| FADS2 | fatty acid desaturase 2 | 1 | 1 |
| FAS | Fas (TNF receptor superfamily, member 6) | 2 | 8 |
| FASLG | Fas ligand (TNF superfamily, member 6) | 1 | 1 |
| FASN | fatty acid synthase | 2 | 2 |
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 1 | 1 |
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 1 | 1 |
| FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | 1 | 2 |
| FCN3 | ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen) | 3 | 2 |
| FCRL5 | Fc receptor-like 5 | 1 | 1 |
| FEN1 | flap structure-specific endonuclease 1 | 1 | 1 |
| FER | fer (fps/fes related) tyrosine kinase | 1 | 2 |
| FES | feline sarcoma oncogene | 1 | 2 |
| FGA | fibrinogen alpha chain | 1 | 1 |
| FGF1 | fibroblast growth factor 1 (acidic) | 1 | 1 |
| FGF2 | fibroblast growth factor 2 (basic) | 4 | 1 |
| FGG | fibrinogen gamma chain | 1 | 1 |
| FGL2 | fibrinogen-like 2 | 1 | 1 |
| FH | fumarate hydratase | 22 | 5 |
| FIS1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) | 1 | 1 |
| FLT3 | fms-related tyrosine kinase 3 | 1 | 2 |
| FN1 | fibronectin 1 | 3 | 4 |
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 2 | 7 |
| FOSL2 | FOS-like antigen 2 | 1 | 1 |
| FOXC1 | forkhead box C1 | 1 | 1 |
| FOXL1 | forkhead box L1 | 1 | 1 |
| FOXO1 | forkhead box O1 | 2 | 2 |
| FOXO4 | forkhead box O4 | 1 | 1 |
| FOXP2 | forkhead box P2 | 1 | 1 |
| FOXP3 | forkhead box P3 | 3 | 7 |
| FPR1 | formyl peptide receptor 1 | 1 | 1 |
| FPR2 | formyl peptide receptor 2 | 1 | 1 |
| FST | follistatin | 5 | 3 |
| FURIN | furin (paired basic amino acid cleaving enzyme) | 32 | 134 |
| FUS | fused in sarcoma | 2 | 5 |
| FUT4 | fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | 1 | 1 |
| FYCO1 | FYVE and coiled-coil domain containing 1 | 1 | 2 |
| G3BP1 | GTPase activating protein (SH3 domain) binding protein 1 | 3 | 2 |
| G6PD | glucose-6-phosphate dehydrogenase | 61 | 31 |
| GABARAP | GABA(A) receptor-associated protein | 1 | 1 |
| GADD45B | growth arrest and DNA-damage-inducible, beta | 1 | 1 |
| GAK | cyclin G associated kinase | 2 | 2 |
| GALT | galactose-1-phosphate uridylyltransferase | 1 | 1 |
| GAN | gigaxonin | 3 | 13 |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 4 | 5 |
| GATA2 | GATA binding protein 2 | 1 | 1 |
| GATA3 | GATA binding protein 3 | 1 | 1 |
| GATA5 | GATA binding protein 5 | 1 | 1 |
| GATA6 | GATA binding protein 6 | 1 | 1 |
| GBA | glucosidase, beta, acid | 1 | 1 |
| GBP1 | guanylate binding protein 1, interferon-inducible | 1 | 1 |
| GC | group-specific component (vitamin D binding protein) | 65 | 58 |
| GCA | grancalcin, EF-hand calcium binding protein | 22 | 3 |
| GCLC | glutamate-cysteine ligase, catalytic subunit | 1 | 2 |
| GDF15 | growth differentiation factor 15 | 2 | 2 |
| GDNF | glial cell derived neurotrophic factor | 2 | 1 |
| GEM | GTP binding protein overexpressed in skeletal muscle | 5 | 1 |
| GK | glycerol kinase | 5 | 2 |
| GLA | galactosidase, alpha | 3 | 4 |
| GLS | glutaminase | 10 | 15 |
| GOLGA3 | golgin A3 | 1 | 1 |
| GPI | glucose-6-phosphate isomerase | 9 | 3 |
| GPNMB | glycoprotein (transmembrane) nmb | 1 | 1 |
| GPR4 | G protein-coupled receptor 4 | 4 | 1 |
| GPR84 | G protein-coupled receptor 84 | 1 | 1 |
| GPX1 | glutathione peroxidase 1 | 5 | 1 |
| GRK6 | G protein-coupled receptor kinase 6 | 1 | 1 |
| GRN | granulin | 4 | 1 |
| GSDMB | gasdermin B | 1 | 1 |
| GSDMD | gasdermin D | 2 | 1 |
| GSS | glutathione synthetase | 1 | 1 |
| GUSB | glucuronidase, beta | 3 | 1 |
| GZMA | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 1 | 1 |
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 1 | 2 |
| HAT1 | histone acetyltransferase 1 | 2 | 3 |
| HBM | hemoglobin, mu | 20 | 14 |
| HDAC2 | histone deacetylase 2 | 3 | 3 |
| HFE | hemochromatosis | 18 | 9 |
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 12 | 6 |
| HGFAC | HGF activator | 1 | 1 |
| HIRA | HIR histone cell cycle regulation defective homolog A (S. cerevisiae) | 1 | 1 |
| HK1 | hexokinase 1 | 1 | 1 |
| HLA-A | major histocompatibility complex, class I, A | 7 | 21 |
| HLA-B | major histocompatibility complex, class I, B | 9 | 14 |
| HLA-C | major histocompatibility complex, class I, C | 1 | 7 |
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 1 | 1 |
| HLA-E | major histocompatibility complex, class I, E | 4 | 3 |
| HLA-F | major histocompatibility complex, class I, F | 1 | 1 |
| HLA-G | major histocompatibility complex, class I, G | 3 | 2 |
| HMGB1 | high mobility group box 1 | 40 | 14 |
| HMOX1 | heme oxygenase (decycling) 1 | 6 | 5 |
| HNF1A | HNF1 homeobox A | 1 | 1 |
| HNF1B | HNF1 homeobox B | 2 | 2 |
| HNF4A | hepatocyte nuclear factor 4, alpha | 3 | 3 |
| HNRNPK | heterogeneous nuclear ribonucleoprotein K | 1 | 1 |
| HP | haptoglobin | 20 | 23 |
| HPD | 4-hydroxyphenylpyruvate dioxygenase | 4 | 3 |
| HPN | hepsin | 5 | 3 |
| HPR | haptoglobin-related protein | 1 | 2 |
| HPS5 | Hermansky-Pudlak syndrome 5 | 1 | 1 |
| HR | hair growth associated | 332 | 515 |
| HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 1 | 1 |
| HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 4 | 3 |
| HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 14 | 3 |
| HYAL1 | hyaluronoglucosaminidase 1 | 1 | 1 |
| ICAM1 | intercellular adhesion molecule 1 | 5 | 4 |
| IDO1 | indoleamine 2,3-dioxygenase 1 | 14 | 3 |
| IDS | iduronate 2-sulfatase | 4 | 10 |
| IFI16 | interferon, gamma-inducible protein 16 | 1 | 1 |
| IFI44 | interferon-induced protein 44 | 1 | 2 |
| IFIH1 | interferon induced with helicase C domain 1 | 5 | 2 |
| IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 | 2 | 5 |
| IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 | 2 | 3 |
| IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 | 2 | 2 |
| IFITM1 | interferon induced transmembrane protein 1 | 4 | 4 |
| IFITM2 | interferon induced transmembrane protein 2 | 4 | 3 |
| IFITM3 | interferon induced transmembrane protein 3 | 22 | 12 |
| IFNA2 | interferon, alpha 2 | 1 | 1 |
| IFNAR1 | interferon (alpha, beta and omega) receptor 1 | 2 | 1 |
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 8 | 6 |
| IFNB1 | interferon, beta 1, fibroblast | 1 | 1 |
| IFNG | interferon, gamma | 4 | 5 |
| IFNL3 | interferon, lambda 3 | 1 | 1 |
| IGF2R | insulin-like growth factor 2 receptor | 1 | 1 |
| IGFBP1 | insulin-like growth factor binding protein 1 | 1 | 1 |
| IGFBP3 | insulin-like growth factor binding protein 3 | 1 | 1 |
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 1 | 1 |
| IL10 | interleukin 10 | 17 | 17 |
| IL10RB | interleukin 10 receptor, beta | 1 | 1 |
| IL13 | interleukin 13 | 1 | 1 |
| IL15 | interleukin 15 | 1 | 1 |
| IL18 | interleukin 18 (interferon-gamma-inducing factor) | 1 | 2 |
| IL1A | interleukin 1, alpha | 3 | 4 |
| IL1B | interleukin 1, beta | 10 | 11 |
| IL2 | interleukin 2 | 5 | 7 |
| IL20 | interleukin 20 | 1 | 1 |
| IL21 | interleukin 21 | 1 | 1 |
| IL32 | interleukin 32 | 1 | 1 |
| IL33 | interleukin 33 | 1 | 2 |
| IL4 | interleukin 4 | 2 | 2 |
| IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 2 | 2 |
| IL6 | interleukin 6 (interferon, beta 2) | 120 | 101 |
| IL6R | interleukin 6 receptor | 2 | 4 |
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 2 | 2 |
| IL7 | interleukin 7 | 1 | 2 |
| IL7R | interleukin 7 receptor | 1 | 1 |
| IL8 | interleukin 8 | 23 | 19 |
| IL9 | interleukin 9 | 1 | 1 |
| INA | internexin neuronal intermediate filament protein, alpha | 1 | 3 |
| INS | insulin | 2 | 13 |
| INSIG1 | insulin induced gene 1 | 1 | 1 |
| IPP | intracisternal A particle-promoted polypeptide | 2 | 1 |
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 1 | 1 |
| IRAK3 | interleukin-1 receptor-associated kinase 3 | 1 | 2 |
| IRAK4 | interleukin-1 receptor-associated kinase 4 | 1 | 1 |
| IRF1 | interferon regulatory factor 1 | 1 | 3 |
| IRF3 | interferon regulatory factor 3 | 5 | 9 |
| IRF5 | interferon regulatory factor 5 | 1 | 1 |
| IRF7 | interferon regulatory factor 7 | 7 | 9 |
| IRF8 | interferon regulatory factor 8 | 1 | 1 |
| IRF9 | interferon regulatory factor 9 | 1 | 2 |
| ISG15 | ISG15 ubiquitin-like modifier | 29 | 15 |
| ISLR | immunoglobulin superfamily containing leucine-rich repeat | 1 | 1 |
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 1 | 1 |
| ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 1 | 1 |
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 2 | 2 |
| ITGA6 | integrin, alpha 6 | 2 | 1 |
| ITGA8 | integrin, alpha 8 | 1 | 1 |
| ITGA9 | integrin, alpha 9 | 1 | 1 |
| ITGAE | integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) | 1 | 1 |
| ITGAV | integrin, alpha V | 1 | 1 |
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 2 | 2 |
| ITGB7 | integrin, beta 7 | 1 | 1 |
| ITK | IL2-inducible T-cell kinase | 1 | 3 |
| IVD | isovaleryl-CoA dehydrogenase | 8 | 10 |
| JAK1 | Janus kinase 1 | 9 | 23 |
| JAK2 | Janus kinase 2 | 8 | 18 |
| JAK3 | Janus kinase 3 | 1 | 1 |
| JUN | jun proto-oncogene | 5 | 21 |
| JUND | jun D proto-oncogene | 1 | 1 |
| KCNJ2 | potassium inwardly-rectifying channel, subfamily J, member 2 | 1 | 1 |
| KDM5B | lysine (K)-specific demethylase 5B | 3 | 3 |
| KIR2DL4 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 | 1 | 1 |
| KL | klotho | 2 | 14 |
| KLF10 | Kruppel-like factor 10 | 1 | 1 |
| KLK13 | kallikrein-related peptidase 13 | 2 | 1 |
| KLRC1 | killer cell lectin-like receptor subfamily C, member 1 | 1 | 1 |
| KLRC2 | killer cell lectin-like receptor subfamily C, member 2 | 1 | 1 |
| KLRF2 | killer cell lectin-like receptor subfamily F, member 2 | 1 | 1 |
| KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 1 | 3 |
| KY | kyphoscoliosis peptidase | 3 | 4 |
| LAG3 | lymphocyte-activation gene 3 | 1 | 1 |
| LAMP1 | lysosomal-associated membrane protein 1 | 1 | 1 |
| LAP3 | leucine aminopeptidase 3 | 1 | 1 |
| LARP1 | La ribonucleoprotein domain family, member 1 | 1 | 2 |
| LAT | linker for activation of T cells | 6 | 2 |
| LBP | lipopolysaccharide binding protein | 16 | 6 |
| LCK | lymphocyte-specific protein tyrosine kinase | 1 | 1 |
| LCT | lactase | 2 | 1 |
| LEP | leptin | 6 | 3 |
| LEPR | leptin receptor | 1 | 1 |
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 1 | 1 |
| LGR4 | leucine-rich repeat containing G protein-coupled receptor 4 | 1 | 1 |
| LGR5 | leucine-rich repeat containing G protein-coupled receptor 5 | 1 | 1 |
| LIFR | leukemia inhibitory factor receptor alpha | 1 | 1 |
| LOX | lysyl oxidase | 1 | 3 |
| LPA | lipoprotein, Lp(a) | 12 | 4 |
| LSR | lipolysis stimulated lipoprotein receptor | 2 | 2 |
| LSS | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 6 | 3 |
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 9 | 3 |
| LTF | lactotransferrin | 2 | 1 |
| LY6E | lymphocyte antigen 6 complex, locus E | 12 | 3 |
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 1 | 1 |
| MACC1 | metastasis associated in colon cancer 1 | 1 | 1 |
| MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 4 | 4 |
| MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | 4 | 1 |
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 1 | 1 |
| MAG | myelin associated glycoprotein | 2 | 3 |
| MAGT1 | magnesium transporter 1 | 1 | 1 |
| MAP2K7 | mitogen-activated protein kinase kinase 7 | 1 | 1 |
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 1 | 1 |
| MAPK1 | mitogen-activated protein kinase 1 | 9 | 8 |
| MAPK11 | mitogen-activated protein kinase 11 | 1 | 1 |
| MAPK14 | mitogen-activated protein kinase 14 | 6 | 6 |
| MAPK3 | mitogen-activated protein kinase 3 | 2 | 3 |
| MAPK8 | mitogen-activated protein kinase 8 | 4 | 4 |
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 1 | 1 |
| MARK3 | MAP/microtubule affinity-regulating kinase 3 | 1 | 1 |
| MARS | methionyl-tRNA synthetase | 4 | 4 |
| MAS1 | MAS1 oncogene | 2 | 5 |
| MASP2 | mannan-binding lectin serine peptidase 2 | 1 | 2 |
| MAST2 | microtubule associated serine/threonine kinase 2 | 1 | 1 |
| MAVS | mitochondrial antiviral signaling protein | 7 | 7 |
| MAX | MYC associated factor X | 11 | 59 |
| MB | myoglobin | 26 | 77 |
| MBL2 | mannose-binding lectin (protein C) 2, soluble | 10 | 3 |
| MCC | mutated in colorectal cancers | 4 | 11 |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 1 | 1 |
| MDH1 | malate dehydrogenase 1, NAD (soluble) | 1 | 1 |
| MDK | midkine (neurite growth-promoting factor 2) | 1 | 1 |
| MDM2 | MDM2 oncogene, E3 ubiquitin protein ligase | 7 | 2 |
| ME1 | malic enzyme 1, NADP(+)-dependent, cytosolic | 1 | 1 |
| MED12L | mediator complex subunit 12-like | 1 | 1 |
| MED9 | mediator complex subunit 9 | 1 | 1 |
| MEP1A | meprin A, alpha (PABA peptide hydrolase) | 1 | 1 |
| MEP1B | meprin A, beta | 1 | 1 |
| MERTK | c-mer proto-oncogene tyrosine kinase | 1 | 1 |
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 12 | 773 |
| MFGE8 | milk fat globule-EGF factor 8 protein | 1 | 2 |
| MGA | MGA, MAX dimerization protein | 1 | 2 |
| MGLL | monoglyceride lipase | 1 | 1 |
| MGMT | O-6-methylguanine-DNA methyltransferase | 3 | 1 |
| MGP | matrix Gla protein | 14 | 4 |
| MIA | melanoma inhibitory activity | 15 | 5 |
| MIP | major intrinsic protein of lens fiber | 3 | 22 |
| MLNR | motilin receptor | 1 | 1 |
| MMD | monocyte to macrophage differentiation-associated | 7 | 4 |
| MME | membrane metallo-endopeptidase | 1 | 3 |
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 2 | 2 |
| MMP13 | matrix metallopeptidase 13 (collagenase 3) | 1 | 1 |
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 1 | 1 |
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 1 | 2 |
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 11 | 2 |
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 1 | 1 |
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 6 | 4 |
| MMRN1 | multimerin 1 | 2 | 1 |
| MMRN2 | multimerin 2 | 2 | 1 |
| MNT | MNT, MAX dimerization protein | 9 | 7 |
| MOG | myelin oligodendrocyte glycoprotein | 3 | 3 |
| MPI | mannose phosphate isomerase | 4 | 4 |
| MPO | myeloperoxidase | 1 | 7 |
| MR1 | major histocompatibility complex, class I-related | 2 | 3 |
| MRGPRD | MAS-related GPR, member D | 1 | 1 |
| MRO | maestro | 10 | 1 |
| MSC | musculin | 122 | 78 |
| MSH3 | mutS homolog 3 (E. coli) | 1 | 1 |
| MSN | moesin | 2 | 2 |
| MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) | 3 | 3 |
| MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) | 3 | 3 |
| MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | 1 | 2 |
| MUC1 | mucin 1, cell surface associated | 4 | 5 |
| MUC16 | mucin 16, cell surface associated | 1 | 1 |
| MUC4 | mucin 4, cell surface associated | 1 | 1 |
| MUC5AC | mucin 5AC, oligomeric mucus/gel-forming | 2 | 1 |
| MUC5B | mucin 5B, oligomeric mucus/gel-forming | 4 | 2 |
| MVD | mevalonate (diphospho) decarboxylase | 4 | 5 |
| MVP | major vault protein | 6 | 3 |
| MX1 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | 16 | 9 |
| MX2 | myxovirus (influenza virus) resistance 2 (mouse) | 8 | 3 |
| MYD88 | myeloid differentiation primary response 88 | 1 | 4 |
| MYO10 | myosin X | 1 | 1 |
| MZB1 | marginal zone B and B1 cell-specific protein | 1 | 1 |
| NACA | nascent polypeptide-associated complex alpha subunit | 2 | 2 |
| NAMPT | nicotinamide phosphoribosyltransferase | 2 | 3 |
| NBN | nibrin | 1 | 1 |
| NBR1 | neighbor of BRCA1 gene 1 | 2 | 1 |
| NCOA1 | nuclear receptor coactivator 1 | 1 | 1 |
| NCOA2 | nuclear receptor coactivator 2 | 1 | 1 |
| NDST1 | N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 | 1 | 1 |
| NDUFA10 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa | 1 | 1 |
| NDUFAF5 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 5 | 1 | 1 |
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase | 1 | 1 |
| NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 1 | 1 |
| NFIA | nuclear factor I/A | 1 | 1 |
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 5 | 5 |
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 2 | 2 |
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 2 | 2 |
| NHS | Nance-Horan syndrome (congenital cataracts and dental anomalies) | 323 | 295 |
| NIN | ninein (GSK3B interacting protein) | 1 | 1 |
| NKG7 | natural killer cell group 7 sequence | 1 | 1 |
| NLRC4 | NLR family, CARD domain containing 4 | 1 | 1 |
| NLRC5 | NLR family, CARD domain containing 5 | 1 | 1 |
| NLRP1 | NLR family, pyrin domain containing 1 | 1 | 2 |
| NLRP12 | NLR family, pyrin domain containing 12 | 2 | 1 |
| NLRP2 | NLR family, pyrin domain containing 2 | 1 | 1 |
| NLRP3 | NLR family, pyrin domain containing 3 | 81 | 49 |
| NLRX1 | NLR family member X1 | 9 | 1 |
| NMB | neuromedin B | 1 | 1 |
| NMS | neuromedin S | 6 | 2 |
| NNT | nicotinamide nucleotide transhydrogenase | 1 | 3 |
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 1 | 1 |
| NOS2 | nitric oxide synthase 2, inducible | 1 | 2 |
| NOX4 | NADPH oxidase 4 | 2 | 2 |
| NOX5 | NADPH oxidase, EF-hand calcium binding domain 5 | 1 | 1 |
| NPC1 | Niemann-Pick disease, type C1 | 16 | 5 |
| NPC2 | Niemann-Pick disease, type C2 | 8 | 2 |
| NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | 1 | 2 |
| NPS | neuropeptide S | 162 | 86 |
| NPW | neuropeptide W | 6 | 1 |
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 1 | 1 |
| NRCAM | neuronal cell adhesion molecule | 1 | 1 |
| NRL | neural retina leucine zipper | 1 | 2 |
| NRM | nurim (nuclear envelope membrane protein) | 11 | 3 |
| NRP1 | neuropilin 1 | 9 | 11 |
| NRP2 | neuropilin 2 | 1 | 2 |
| NSF | N-ethylmaleimide-sensitive factor | 3 | 1 |
| NTNG1 | netrin G1 | 1 | 2 |
| NTS | neurotensin | 8 | 5 |
| NUDC | nuclear distribution C homolog (A. nidulans) | 1 | 1 |
| NUDT15 | nudix (nucleoside diphosphate linked moiety X)-type motif 15 | 1 | 1 |
| NUP98 | nucleoporin 98kDa | 2 | 3 |
| NXF1 | nuclear RNA export factor 1 | 3 | 1 |
| OAS1 | 2’-5’-oligoadenylate synthetase 1, 40/46kDa | 2 | 2 |
| OAS2 | 2’-5’-oligoadenylate synthetase 2, 69/71kDa | 3 | 4 |
| OAS3 | 2’-5’-oligoadenylate synthetase 3, 100kDa | 1 | 1 |
| OAT | ornithine aminotransferase | 24 | 8 |
| OPTN | optineurin | 2 | 2 |
| ORM2 | orosomucoid 2 | 1 | 1 |
| OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin | 2 | 1 |
| OTC | ornithine carbamoyltransferase | 1 | 4 |
| OTP | orthopedia homeobox | 9 | 3 |
| OXT | oxytocin/neurophysin I prepropeptide | 10 | 2 |
| PADI1 | peptidyl arginine deiminase, type I | 1 | 1 |
| PADI2 | peptidyl arginine deiminase, type II | 4 | 1 |
| PADI3 | peptidyl arginine deiminase, type III | 2 | 1 |
| PADI4 | peptidyl arginine deiminase, type IV | 4 | 1 |
| PADI6 | peptidyl arginine deiminase, type VI | 3 | 1 |
| PAH | phenylalanine hydroxylase | 29 | 15 |
| PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | 4 | 4 |
| PALB2 | partner and localizer of BRCA2 | 1 | 1 |
| PALM | paralemmin | 1 | 12 |
| PAM | peptidylglycine alpha-amidating monooxygenase | 2 | 6 |
| PANX1 | pannexin 1 | 5 | 1 |
| PARL | presenilin associated, rhomboid-like | 2 | 1 |
| PARP1 | poly (ADP-ribose) polymerase 1 | 11 | 4 |
| PARP14 | poly (ADP-ribose) polymerase family, member 14 | 3 | 1 |
| PC | pyruvate carboxylase | 116 | 52 |
| PCSK9 | proprotein convertase subtilisin/kexin type 9 | 7 | 5 |
| PDC | phosducin | 5 | 6 |
| PDCD1 | programmed cell death 1 | 1 | 1 |
| peptide deformylase (mitochondrial) | 3 | 20 | |
| PF4 | platelet factor 4 | 2 | 4 |
| PFAS | phosphoribosylformylglycinamidine synthase | 2 | 1 |
| PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 3 | 3 |
| PGD | phosphogluconate dehydrogenase | 11 | 5 |
| PGK1 | phosphoglycerate kinase 1 | 1 | 1 |
| PGM5 | phosphoglucomutase 5 | 1 | 1 |
| PGR | progesterone receptor | 2 | 2 |
| PHB | prohibitin | 1 | 3 |
| PHB2 | prohibitin 2 | 1 | 1 |
| PI3 | peptidase inhibitor 3, skin-derived | 1 | 3 |
| PID1 | phosphotyrosine interaction domain containing 1 | 1 | 1 |
| PIKFYVE | phosphoinositide kinase, FYVE finger containing | 1 | 7 |
| PINK1 | PTEN induced putative kinase 1 | 1 | 1 |
| PIP | prolactin-induced protein | 6 | 9 |
| PIR | pirin (iron-binding nuclear protein) | 2 | 3 |
| PKP2 | plakophilin 2 | 1 | 1 |
| PLA2G2D | phospholipase A2, group IID | 1 | 1 |
| PLAT | plasminogen activator, tissue | 2 | 3 |
| PLG | plasminogen | 7 | 3 |
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 8 | 3 |
| PML | promyelocytic leukemia | 5 | 4 |
| PNN | pinin, desmosome associated protein | 1 | 1 |
| POLD4 | polymerase (DNA-directed), delta 4, accessory subunit | 1 | 1 |
| POMC | proopiomelanocortin | 1 | 1 |
| PON2 | paraoxonase 2 | 1 | 1 |
| POR | P450 (cytochrome) oxidoreductase | 7 | 133 |
| PPARG | peroxisome proliferator-activated receptor gamma | 1 | 2 |
| PPIA | peptidylprolyl isomerase A (cyclophilin A) | 2 | 3 |
| PPL | periplakin | 1 | 1 |
| PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 1 | 1 |
| PRAC | prostate cancer susceptibility candidate | 1 | 1 |
| PRCC | papillary renal cell carcinoma (translocation-associated) | 2 | 4 |
| PRDX3 | peroxiredoxin 3 | 1 | 1 |
| PREP | prolyl endopeptidase | 2 | 32 |
| PRKCA | protein kinase C, alpha | 1 | 2 |
| PRKCB | protein kinase C, beta | 2 | 3 |
| PRL | prolactin | 7 | 4 |
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 2 | 3 |
| PROS1 | protein S (alpha) | 2 | 3 |
| PRRT2 | proline-rich transmembrane protein 2 | 1 | 1 |
| PRSS1 | protease, serine, 1 (trypsin 1) | 2 | 1 |
| PSAP | prosaposin | 4 | 1 |
| PSD | pleckstrin and Sec7 domain containing | 7 | 1 |
| PTAFR | platelet-activating factor receptor | 1 | 1 |
| PTBP1 | polypyrimidine tract binding protein 1 | 3 | 1 |
| PTEN | phosphatase and tensin homolog | 3 | 2 |
| PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 1 | 2 |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 8 | 10 |
| PTH | parathyroid hormone | 6 | 5 |
| PTS | 6-pyruvoyltetrahydropterin synthase | 8 | 8 |
| PTX3 | pentraxin 3, long | 11 | 2 |
| PVR | poliovirus receptor | 5 | 4 |
| RAB18 | RAB18, member RAS oncogene family | 1 | 1 |
| RAB1A | RAB1A, member RAS oncogene family | 1 | 1 |
| RAB7A | RAB7A, member RAS oncogene family | 1 | 1 |
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 1 | 1 |
| RAD17 | RAD17 homolog (S. pombe) | 1 | 1 |
| RAD51C | RAD51 homolog C (S. cerevisiae) | 2 | 1 |
| RAD51D | RAD51 homolog D (S. cerevisiae) | 1 | 1 |
| RAE1 | RAE1 RNA export 1 homolog (S. pombe) | 1 | 2 |
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 1 | 1 |
| RAG2 | recombination activating gene 2 | 4 | 1 |
| RAMP1 | receptor (G protein-coupled) activity modifying protein 1 | 2 | 1 |
| RARA | retinoic acid receptor, alpha | 1 | 2 |
| RBX1 | ring-box 1, E3 ubiquitin protein ligase | 1 | 2 |
| REEP5 | receptor accessory protein 5 | 1 | 1 |
| REEP6 | receptor accessory protein 6 | 1 | 1 |
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 6 | 6 |
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 6 | 9 |
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 1 | 1 |
| REST | RE1-silencing transcription factor | 2 | 423 |
| RET | ret proto-oncogene | 2 | 1 |
| RETN | resistin | 1 | 1 |
| RFC1 | replication factor C (activator 1) 1, 145kDa | 1 | 1 |
| RHO | rhodopsin | 2 | 41 |
| RHOA | ras homolog family member A | 2 | 2 |
| RHOT2 | ras homolog family member T2 | 1 | 1 |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 5 | 2 |
| RNASEL | ribonuclease L (2’,5’-oligoisoadenylate synthetase-dependent) | 1 | 1 |
| RP2 | retinitis pigmentosa 2 (X-linked recessive) | 6 | 3 |
| RPA2 | replication protein A2, 32kDa | 1 | 1 |
| RPE | ribulose-5-phosphate-3-epimerase | 18 | 11 |
| RPP30 | ribonuclease P/MRP 30kDa subunit | 4 | 5 |
| RPS6KB1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | 1 | 1 |
| RPS8 | ribosomal protein S8 | 1 | 1 |
| RRH | retinal pigment epithelium-derived rhodopsin homolog | 1 | 1 |
| RSAD2 | radical S-adenosyl methionine domain containing 2 | 2 | 2 |
| RUNX1 | runt-related transcription factor 1 | 1 | 1 |
| RXRA | retinoid X receptor, alpha | 1 | 1 |
| S100A12 | S100 calcium binding protein A12 | 1 | 1 |
| S100A4 | S100 calcium binding protein A4 | 1 | 1 |
| S100A8 | S100 calcium binding protein A8 | 3 | 8 |
| S100A9 | S100 calcium binding protein A9 | 3 | 3 |
| S100B | S100 calcium binding protein B | 5 | 2 |
| SAA2 | serum amyloid A2 | 1 | 1 |
| SAMHD1 | SAM domain and HD domain 1 | 3 | 1 |
| SAMM50 | sorting and assembly machinery component 50 homolog (S. cerevisiae) | 1 | 1 |
| SARS2 | seryl-tRNA synthetase 2, mitochondrial | 11 | 12 |
| SCAP | SREBF chaperone | 10 | 3 |
| SCARB1 | scavenger receptor class B, member 1 | 1 | 1 |
| SCD | stearoyl-CoA desaturase (delta-9-desaturase) | 63 | 27 |
| SCT | secretin | 13 | 9 |
| SDC2 | syndecan 2 | 2 | 1 |
| SDHB | succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | 2 | 1 |
| SDS | serine dehydratase | 24 | 34 |
| SELE | selectin E | 1 | 1 |
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 1 | 3 |
| SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 2 | 2 |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 1 | 1 |
| SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 1 | 1 |
| SFN | stratifin | 5 | 2 |
| SFTPC | surfactant protein C | 2 | 2 |
| SGCE | sarcoglycan, epsilon | 1 | 1 |
| SGTA | small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha | 1 | 1 |
| SHD | Src homology 2 domain containing transforming protein D | 12 | 7 |
| SHF | Src homology 2 domain containing F | 1 | 1 |
| SI | sucrase-isomaltase (alpha-glucosidase) | 55 | 66 |
| SIGMAR1 | sigma non-opioid intracellular receptor 1 | 1 | 1 |
| SIRT1 | sirtuin 1 | 25 | 11 |
| SIRT2 | sirtuin 2 | 6 | 1 |
| SIRT3 | sirtuin 3 | 2 | 1 |
| SIRT4 | sirtuin 4 | 4 | 1 |
| SIRT5 | sirtuin 5 | 4 | 1 |
| SIRT6 | sirtuin 6 | 5 | 2 |
| SIRT7 | sirtuin 7 | 4 | 1 |
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 6 | 8 |
| SKP2 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase | 1 | 2 |
| SLA | Src-like-adaptor | 2 | 1 |
| SLC19A1 | solute carrier family 19 (folate transporter), member 1 | 1 | 1 |
| SLC27A2 | solute carrier family 27 (fatty acid transporter), member 2 | 1 | 1 |
| SLC28A2 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 | 1 | 2 |
| SLC34A3 | solute carrier family 34 (sodium phosphate), member 3 | 1 | 1 |
| SLC6A19 | solute carrier family 6 (neutral amino acid transporter), member 19 | 3 | 4 |
| SLC6A20 | solute carrier family 6 (proline IMINO transporter), member 20 | 1 | 3 |
| SLC7A11 | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 | 1 | 1 |
| SLC9A7 | solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 | 1 | 1 |
| SLCO1A2 | solute carrier organic anion transporter family, member 1A2 | 1 | 2 |
| SLCO1B1 | solute carrier organic anion transporter family, member 1B1 | 1 | 4 |
| SLN | sarcolipin | 3 | 1 |
| SLX4 | SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae) | 1 | 1 |
| SMN1 | survival of motor neuron 1, telomeric | 3 | 1 |
| SMS | spermine synthase | 48 | 38 |
| SNN | stannin | 3 | 1 |
| SOCS1 | suppressor of cytokine signaling 1 | 3 | 2 |
| SOCS3 | suppressor of cytokine signaling 3 | 5 | 4 |
| SOD1 | superoxide dismutase 1, soluble | 5 | 2 |
| SOD2 | superoxide dismutase 2, mitochondrial | 1 | 2 |
| SON | SON DNA binding protein | 3 | 48 |
| SOS1 | son of sevenless homolog 1 (Drosophila) | 1 | 1 |
| SP1 | Sp1 transcription factor | 3 | 3 |
| SPECC1 | sperm antigen with calponin homology and coiled-coil domains 1 | 1 | 1 |
| SPR | sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) | 17 | 22 |
| SQSTM1 | sequestosome 1 | 1 | 1 |
| SRF | serum response factor (c-fos serum response element-binding transcription factor) | 10 | 5 |
| SRI | sorcin | 9 | 21 |
| SRL | sarcalumenin | 6 | 8 |
| SRM | spermidine synthase | 4 | 4 |
| SRP9 | signal recognition particle 9kDa | 1 | 1 |
| SST | somatostatin | 4 | 6 |
| STAR | steroidogenic acute regulatory protein | 3 | 30 |
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 15 | 19 |
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 3 | 4 |
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 28 | 29 |
| STAT5A | signal transducer and activator of transcription 5A | 1 | 2 |
| STH | saitohin | 4 | 3 |
| STS | steroid sulfatase (microsomal), isozyme S | 18 | 19 |
| STX17 | syntaxin 17 | 1 | 1 |
| SUMO1 | SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) | 2 | 1 |
| SYCP2 | synaptonemal complex protein 2 | 1 | 1 |
| SYK | spleen tyrosine kinase | 2 | 3 |
| SYTL2 | synaptotagmin-like 2 | 1 | 1 |
| TAF4 | TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa | 1 | 1 |
| TAF5 | TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 100kDa | 1 | 1 |
| TAF7L | TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, 50kDa | 1 | 1 |
| TANK | TRAF family member-associated NFKB activator | 1 | 10 |
| TAS2R10 | taste receptor, type 2, member 10 | 3 | 1 |
| TAT | tyrosine aminotransferase | 16 | 12 |
| TBCA | tubulin folding cofactor A | 4 | 1 |
| TBCC | tubulin folding cofactor C | 4 | 1 |
| TBK1 | TANK-binding kinase 1 | 4 | 4 |
| TCF12 | transcription factor 12 | 1 | 1 |
| TCF4 | transcription factor 4 | 1 | 1 |
| TERT | telomerase reverse transcriptase | 1 | 3 |
| TET2 | tet methylcytosine dioxygenase 2 | 7 | 1 |
| TF | transferrin | 50 | 35 |
| TFEB | transcription factor EB | 1 | 1 |
| TFF2 | trefoil factor 2 | 9 | 2 |
| TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 1 | 1 |
| TFRC | transferrin receptor (p90, CD71) | 1 | 1 |
| TG | thyroglobulin | 23 | 17 |
| TGFB1 | transforming growth factor, beta 1 | 3 | 3 |
| TH | tyrosine hydroxylase | 34 | 202 |
| TIGIT | T cell immunoreceptor with Ig and ITIM domains | 2 | 4 |
| TIMM10 | translocase of inner mitochondrial membrane 10 homolog (yeast) | 1 | 1 |
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 1 | 1 |
| TLE3 | transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) | 1 | 1 |
| TLR2 | toll-like receptor 2 | 4 | 7 |
| TLR3 | toll-like receptor 3 | 19 | 22 |
| TLR4 | toll-like receptor 4 | 31 | 24 |
| TLR5 | toll-like receptor 5 | 1 | 2 |
| TLR6 | toll-like receptor 6 | 1 | 1 |
| TLR7 | toll-like receptor 7 | 20 | 15 |
| TLR8 | toll-like receptor 8 | 6 | 6 |
| TLR9 | toll-like receptor 9 | 11 | 12 |
| TMEM106B | transmembrane protein 106B | 1 | 1 |
| TMEM41B | transmembrane protein 41B | 5 | 2 |
| TMEM64 | transmembrane protein 64 | 1 | 1 |
| TMEM97 | transmembrane protein 97 | 2 | 2 |
| TMPRSS11A | transmembrane protease, serine 11A | 9 | 3 |
| TMPRSS11D | transmembrane protease, serine 11D | 5 | 3 |
| TMPRSS2 | transmembrane protease, serine 2 | 751 | 392 |
| TMPRSS4 | transmembrane protease, serine 4 | 8 | 4 |
| TNC | tenascin C | 1 | 1 |
| TNF | tumor necrosis factor | 115 | 375 |
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 2 | 1 |
| TNFRSF13C | tumor necrosis factor receptor superfamily, member 13C | 1 | 1 |
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 1 | 1 |
| TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 | 1 | 1 |
| TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 | 1 | 1 |
| TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 2 | 3 |
| TNKS2 | tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 | 2 | 1 |
| TNR | tenascin R | 1 | 1 |
| TOP3B | topoisomerase (DNA) III beta | 2 | 1 |
| TP53 | tumor protein p53 | 11 | 12 |
| TP53INP1 | tumor protein p53 inducible nuclear protein 1 | 1 | 1 |
| TPMT | thiopurine S-methyltransferase | 1 | 1 |
| TPO | thyroid peroxidase | 1 | 2 |
| TPR | translocated promoter region, nuclear basket protein | 5 | 4 |
| TRA | T cell receptor alpha locus | 1 | 2 |
| TRAF3 | TNF receptor-associated factor 3 | 2 | 2 |
| TRAF6 | TNF receptor-associated factor 6, E3 ubiquitin protein ligase | 1 | 1 |
| TRAP1 | TNF receptor-associated protein 1 | 1 | 2 |
| TRD | T cell receptor delta locus | 8 | 3 |
| TREM2 | triggering receptor expressed on myeloid cells 2 | 2 | 2 |
| TRIB3 | tribbles homolog 3 (Drosophila) | 2 | 2 |
| TRIM21 | tripartite motif containing 21 | 4 | 3 |
| TRIM22 | tripartite motif containing 22 | 1 | 1 |
| TRIM34 | tripartite motif containing 34 | 1 | 1 |
| TRIM5 | tripartite motif containing 5 | 3 | 1 |
| TRIM56 | tripartite motif containing 56 | 4 | 1 |
| TRNT1 | tRNA nucleotidyl transferase, CCA-adding, 1 | 1 | 1 |
| TRPA1 | transient receptor potential cation channel, subfamily A, member 1 | 5 | 4 |
| TRPV1 | transient receptor potential cation channel, subfamily V, member 1 | 11 | 5 |
| TRPV4 | transient receptor potential cation channel, subfamily V, member 4 | 7 | 2 |
| TSLP | thymic stromal lymphopoietin | 1 | 1 |
| TST | thiosulfate sulfurtransferase (rhodanese) | 6 | 5 |
| TTF1 | transcription termination factor, RNA polymerase I | 2 | 2 |
| TTR | transthyretin | 8 | 4 |
| TXNIP | thioredoxin interacting protein | 2 | 2 |
| TYK2 | tyrosine kinase 2 | 2 | 2 |
| TYMP | thymidine phosphorylase | 1 | 2 |
| TYR | tyrosinase | 1 | 5 |
| TYRO3 | TYRO3 protein tyrosine kinase | 1 | 2 |
| UBA52 | ubiquitin A-52 residue ribosomal protein fusion product 1 | 1 | 1 |
| UBC | ubiquitin C | 1 | 3 |
| UCP2 | uncoupling protein 2 (mitochondrial, proton carrier) | 1 | 1 |
| ULK1 | unc-51-like kinase 1 (C. elegans) | 1 | 2 |
| UNC93B1 | unc-93 homolog B1 (C. elegans) | 1 | 1 |
| USP13 | ubiquitin specific peptidase 13 (isopeptidase T-3) | 6 | 1 |
| USP2 | ubiquitin specific peptidase 2 | 1 | 1 |
| VAV1 | vav 1 guanine nucleotide exchange factor | 1 | 1 |
| VCAN | versican | 1 | 1 |
| VCP | valosin containing protein | 8 | 2 |
| VIP | vasoactive intestinal peptide | 51 | 73 |
| VIT | vitrin | 11 | 6 |
| VKORC1 | vitamin K epoxide reductase complex, subunit 1 | 3 | 4 |
| VMP1 | vacuole membrane protein 1 | 2 | 2 |
| VPRBP | Vpr (HIV-1) binding protein | 1 | 1 |
| VPS39 | vacuolar protein sorting 39 homolog (S. cerevisiae) | 2 | 1 |
| VWF | von Willebrand factor | 59 | 30 |
| WARS | tryptophanyl-tRNA synthetase | 2 | 12 |
| XIAP | X-linked inhibitor of apoptosis | 1 | 1 |
| XPNPEP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound | 1 | 1 |
| XPO1 | exportin 1 (CRM1 homolog, yeast) | 2 | 2 |
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 1 | 1 |
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 1 | 1 |
| YY1 | YY1 transcription factor | 1 | 1 |
| ZBP1 | Z-DNA binding protein 1 | 1 | 1 |
| ZNF608 | zinc finger protein 608 | 1 | 1 |